DOLPHMED trading today higher at ₹7.49, an increase of 4.902% from yesterday's close, completing a monthly decrease of -17.8728% or -₹1.63. Over the past 12 months, DOLPHMED stock gained 155.6314%.
DOLPHMED is not paying dividends to its shareholders.
The last earnings report, released on Feb 09, 2026, exceeded the consensus estimates by 0.0111%. On average, the company has surpassed earnings expectations by 0.0119%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.